Holocene Advisors’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-93,153
Closed -$1.19M 804
2023
Q4
$1.19M Hold
93,153
﹤0.01% 595
2023
Q3
$962K Hold
93,153
﹤0.01% 641
2023
Q2
$1.22M Buy
+93,153
New +$1.14M 0.01% 617
2022
Q2
Sell
-13,323
Closed -$331K 923
2022
Q1
$331K Sell
13,323
-28,805
-68% -$744K ﹤0.01% 795
2021
Q4
$1.35M Sell
42,128
-12,018
-22% -$439K 0.01% 629
2021
Q3
$1.95M Buy
54,146
+31,409
+138% +$1.24M 0.01% 563
2021
Q2
$1M Buy
+22,737
New +$990K 0.01% 661

Other funds holding LUNG

Holocene Advisors's LUNG Position: Q1 2024 in Review

Holocene Advisors sold out of Pulmonx (LUNG) in Q1 2024, closing a stake of 93,153 shares — an estimated $1.19M sold.

Holocene Advisors first reported a position in LUNG in Q2 2021 and held it in 7 quarters. The position peaked at $1.95M in Q3 2021. 118 funds tracked by Wall St. Rank hold LUNG as of Q1 2024.

  • Holocene Advisors reported no remaining Pulmonx position as of Q1 2024 after selling out during the quarter.
  • Holocene Advisors sold 93,153 Pulmonx shares in Q1 2024, an estimated $1.19M.
  • Holocene Advisors first reported a position in Pulmonx in Q2 2021 and held it in 7 quarters.
  • Holocene Advisors's Pulmonx position peaked at $1.95M in Q3 2021.
  • 118 funds tracked by Wall St. Rank held Pulmonx as of Q1 2024.

Based on Holocene Advisors's 13F filing for Q1 2024, filed 15 May 2024.